Alnylam Pharmaceuticals | Zinsertrag

Aktienkurs
328.16
Täglich Wechseln
-3.08 -0.93%
Monatlich
-22.33%
Jährlich
18.82%
Q1 Prognose
318.09




Zinsertrag Veränderung Datum
Acadia Pharmaceuticals USD 7.24M 658K 2025-06
Agios Pharmaceuticals USD 14.51M 1.57M 2025-06
Alnylam Pharmaceuticals USD 27.49M 1.19M 2025-06
Arrowhead Research USD 9.05M 1.97M 2025-09
BioMarin Pharmaceutical USD 18.83M 186K 2025-06
Incyte USD 25.14M 2.21M 2025-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Moderna USD 81M 9M 2025-06
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 7.14M 3.05M 2025-06
Takeda JPY 87.87B 43.48B 2025-12
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 5.79M 1.04M 2025-06
Vertex Pharmaceuticals USD 122.4M 1.5M 2025-06
Xencor USD 7.25M 290K 2025-06


Alnylam Pharmaceuticals Zinsertrag - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.